2023-09-28
14:00:00
Guard Therapeutics ger fördjupad information om utvecklingsstrategin för RMC-035
2023-07-14
11:15:00
Last patient visit completed in Guard Therapeutics' clinical Phase 2 study AKITA
Visa fler
![arrow-icon](/assets/img/icons/arrow-down.png)